These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33406148)

  • 1. Correction: Antimalarial drug resistance molecular markers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Hamid MMA; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2021; 16(1):e0245336. PubMed ID: 33406148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
    Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
    Bakhiet AMA; Abdelraheem MH; Kheir A; Omer S; Gismelseed L; Abdel-Muhsin AA; Naiem A; Al Hosni A; Al Dhuhli A; Al Rubkhi M; Al-Hamidhi S; Gadalla A; Mukhtar M; Sultan AA; Babiker HA
    Trans R Soc Trop Med Hyg; 2019 Nov; 113(11):693-700. PubMed ID: 31369106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan.
    Mohamed AO; Hussien M; Mohamed A; Suliman A; Elkando NS; Abdelbagi H; Malik EM; Abdelraheem MH; Hamid MMA
    Malar J; 2020 Feb; 19(1):78. PubMed ID: 32070355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress in researches on molecular markers of non-
    Jing C; Mei-Hua Z; Jian-Xia T; Yao-Bao L; Jun C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2018 Aug; 30(4):465-471. PubMed ID: 30350518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications.
    Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Ouattara A; Takala-Harrison S; Berry AA; Doumbo OK; Plowe CV
    PLoS One; 2016; 11(1):e0148240. PubMed ID: 26820850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Targeting of a Transporter to the Outer Apicoplast Membrane in the Human Malaria Parasite Plasmodium falciparum.
    PLOS ONE Staff
    PLoS One; 2016; 11(8):e0161420. PubMed ID: 27548067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
    Partey FD; Castberg FC; Sarbah EW; Silk SE; Awandare GA; Draper SJ; Opoku N; Kweku M; Ofori MF; Hviid L; Barfod L
    PLoS One; 2018; 13(9):e0204452. PubMed ID: 30222763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria.
    Chaorattanakawee S; Nuchnoi P; Hananantachai H; Tumkosit U; Saunders D; Naka I; Ohashi J; Patarapotikul J
    PLoS One; 2018; 13(4):e0196694. PubMed ID: 29694418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.
    Parola P; Pradines B; Simon F; Carlotti MP; Minodier P; Ranjeva MP; Badiaga S; Bertaux L; Delmont J; Morillon M; Silai R; Brouqui P; Parzy D
    Am J Trop Med Hyg; 2007 Sep; 77(3):431-7. PubMed ID: 17827355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
    Chitnis CE; Mukherjee P; Mehta S; Yazdani SS; Dhawan S; Shakri AR; Bhardwaj R; Gupta PK; Hans D; Mazumdar S; Singh B; Kumar S; Pandey G; Parulekar V; Imbault N; Shivyogi P; Godbole G; Mohan K; Leroy O; Singh K; Chauhan VS
    PLoS One; 2015; 10(9):e0137816. PubMed ID: 26332825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Profiles of Plasmodium falciparum infections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana.
    Botwe AK; Owusu-Agyei S; Asghar M; Hammar U; Oppong FB; Gyaase S; Dosoo D; Jakpa G; Boamah E; Twumasi MF; Osier F; Färnert A; Asante KP
    PLoS One; 2021; 16(2):e0246773. PubMed ID: 33534827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance.
    Awad-el-Kariem FM; Miles MA; Warhurst DC
    Trans R Soc Trop Med Hyg; 1992; 86(6):587-9. PubMed ID: 1287907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro.
    Lithanatudom P; Wipasa J; Inti P; Chawansuntati K; Svasti S; Fucharoen S; Kangwanpong D; Kampuansai J
    PLoS One; 2016; 11(9):e0163430. PubMed ID: 27631391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
    Nour BY; Faragalla IA; Saeed OK; Mohamadani AA
    Saudi Med J; 2006 Jun; 27(6):808-12. PubMed ID: 16758040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Identification of Plasmodium falciparum DNA Repair Protein Mre11 with an Evolutionarily Conserved Nuclease Function.
    Badugu SB; Nabi SA; Vaidyam P; Laskar S; Bhattacharyya S; Bhattacharyya MK
    PLoS One; 2023; 18(10):e0293936. PubMed ID: 37906581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular epidemiological surveillance of markers for antimalarial drugs in Plasmodium falciparum isolates imported to Barcelona, Spain].
    Gascón J; Mayor A; Mühlberger N; Peyerl-Hoffmann G; Oliveira I; Dobaño C; Jelinek T; Corachan M
    Med Clin (Barc); 2005 Sep; 125(8):286-9. PubMed ID: 16159551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of Plasmodium falciparum to antimalarial drugs in vitro at Wad Medani, Sudan.
    Ihrahim AM
    APMIS Suppl; 1988; 3():44-6. PubMed ID: 3052537
    [No Abstract]   [Full Text] [Related]  

  • 20. Correction: Genotypic glucose-6-phosphate dehydrogenase (G6PD) deficiency protects against Plasmodium falciparum infection in individuals living in Ghana.
    Amoah LE; Asare KK; Dickson D; Abankwa J; Busayo A; Bredu D; Annan S; Asumah GA; Peprah NY; Asamoah A; Malm KL
    PLoS One; 2023; 18(11):e0294702. PubMed ID: 37967114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.